معرفی
Marek Chawarski is a Professor of Psychiatry and Emergency Medicine at Yale School of Medicine, with joint appointments in both departments. He is affiliated with the Connecticut Mental Health Center, the Yale Global Mental Health Program, and the Yale Institute for Global Health, reflecting his strong commitment to public health and global research. His academic work bridges clinical psychiatry, emergency care, and substance use intervention.
- PhD, Yale University, Psychology (1995)
- MPhil, Yale University, Psychology (1993)
- MS, Yale University, Psychology/Cognitive (1992)
- MA, Jagiellonian University, Psychology/Clinical, Cognitive (1987)
Dr. Chawarski's research focuses on substance use disorders, particularly opioid and amphetamine-related disorders, harm reduction strategies, and HIV prevention among people who inject drugs. His work emphasizes implementation science, global health, and health equity, with field research conducted in Malaysia, China, Indonesia, Iran, Russia, and Taiwan. He has led and contributed to numerous clinical trials evaluating buprenorphine and other medications for addiction treatment.
His recent publications highlight emerging trends in emergency department-initiated buprenorphine, integration of MOUD in community settings, racial disparities in treatment access, and the phytochemical analysis of kratom. These works reflect a strong interdisciplinary approach combining clinical research, public health, pharmacology, and social science perspectives.
His scientific awards include:
- Honorary Guest Professorship, Central South University, China (2015)
- NIDA International Program Award of Excellence (2014)
- Honorary Guest Professorship, Wuhan CDC, China (2008)
Dr. Chawarski has been actively involved in teaching and international research collaborations. He has received grant funding for studies on substance abuse treatment and HIV prevention, and his work supports policy development and service delivery improvements. He collaborates extensively with researchers such as Patrick G. O'Connor, Gail D'Onofrio, David Fiellin, and Edouard Coupet II.
He is a key member of research teams focused on addiction medicine and emergency psychiatry, contributing to initiatives like the ED-Initiated Buprenorphine program and the Yale Program in Addiction Medicine.